In the Media


Apr. 3, 2017 Rapid Diagnosis of Invasive Candidiasis
  Clinical Lab Products
Mar. 8, 2017

Test May Yield More Accurate Antifungal Therapy

  Pharmacy Practice News
Feb. 17, 2017

New data shows use of T2 Biosystem’s diagnostic panel for rapid detection of sepsis, caused by Candida, could save hospitals millions of dollars annually

  Becker's Hospital Review
Feb. 10, 2017 T2MR Technology and its Ability to Offer new Insights into Hemostasis
Nov. 12, 2016 At AMP Meeting, T2 Reports Annual Cost Saving of Up to $3M for Hospital Using Rapid Sepsis MDx


Sep. 28, 2016 7 Medtech Discovery of the Decade Nominees—T2Candida Panel
  Medical Device and Diagnostic Industry
Aug. 31, 2016 Taking Aim at Sepsis
  Clinical Lab Products
Aug. 23, 2016 The Ultimate Battle Against MRSA
  Diagnostic Testing and Emerging Technology
Aug. 12, 2016 Novel MR-Based Test Shortens Sepsis Detection Time
Jul. 28, 2016 Emerging Methodology: A Game-Changer in the Always-Urgent Detection of Sepsis
  Advance for the Laboratory
Jun. 26, 2016 Fastest-Growing Public Companies in Massachusetts
  Boston Business Journal
Jun. 21, 2016 50 Smartest Companies 2016
  MIT Technology Review
Jun. 14, 2016 Superbug Hearing: Will Congress Pick Up Ali's Fight Against Sepsis?
Jun. 3, 2016 Study Shows MRI Technology Faster At Diagnosing Sepsis
  Medical Device and Diagnostic Industry 
May 31, 2016 John McDonough Recognized as One of the Top 10 Most Creative People in Business
  Fast Company
Mar. 25, 2016 Executive Profile: Building a Billion-Dollar Business to Take on Health Care’s Biggest Killer 
  Boston Business Journal
Mar. 2016 A Blood Scan for Sepsis?
  The Clinical Chemist
Feb. 16, 2016 T2 Biosystems Hopes to Gain Market Share with Sepsis Detection Technologies
  Medical Device Daily
Jan. 2016 T2Bacteria Panel study results, 1/16
  Cap Today


Dec. 1, 2015 T2 Biosystems Has Strong Diagnostic Tool in Fight Against Sepsis
  G2 Intelligence
Dec. 1, 2015 Panel Demonstrates Detection of Six Clinically Relevant Bacteria Species Directly from Whole Blood
  Clinical Laboratories
Nov. 12, 2015 Can A New Test Help Hospitals Fight Sepsis?
  KQED Science
Nov. 12, 2015 Lexington Firm’s New Sepsis Test Places it Among Life Sciences Giants
  Boston Business Journal
Nov. 6, 2015 New Machine Cuts Sepsis Diagnosis to Just Five Hours
  Wired UK
Nov. 4, 2015 New Sepsis Detector Shrinks the Diagnosis from Days to Hours
  MIT Technology Review
Oct. 29, 2015 T2 Biosystems' T2Candida Panel Named Best Medical Technology Product at Prix Galien USA Awards
Aug. 19, 2015 T2 Biosystems Shifts Paradigm for Rapid Pathogen Identification Directly From Sample
  Diagnostic Testing & Emerging Technologies
Jul. 9, 2015 New Diagnostic Detects Sepsis in Three Hours
  Bioscience Technology
Jul. 7, 2015 Sepsis Diagnostics: The Role of Laboratory Testing in Identifying Sepsis and MDROs
  Advance for Laboratory
Jun. 16, 2015 Diagnostic Panel Improves Detection of Candida Infections vs. Blood Cultures (Investigational Study)
  Healio Infectious Disease in Children
Jun. 2, 2015 Data From Investigational Study Demonstrates T2Candida® Panel Provides Accurate and Fast Diagnosis of Candida, a Leading Cause of Sepsis, With Only 2mL of Blood From Pediatric Patients
Apr. 17, 2015 Critical Stressors in the Microbiology Lab: Four Cs
  CAP Today
Apr. 13. 2015 New Study Describes Economic Consequences of Using T2Candida Panel for Detection of Candidemia
  News Medical
Apr. 8, 2015 Study Published in Future Microbiology Demonstrates Significant Cost and Survival Benefits for T2 Biosystems' T2Candida Panel for Sepsis
Apr. 8, 2015 Total Annual Hospital Costs Could be Reduced by Rapid Candidemia Identification
  Medical Xpres
Feb. 20, 2015 With MRI Platform, Mass. Firm Aims To Upend Sepsis Diagnosis
  Medical Device & Diagnostic Industry
Jan. 16, 2015 T2 Biosystems Candida Sepsis Test Proves Value in Clinical Study
  GenomeWeb Daily News


Dec. 22, 2014 Diagnostic Testing for Fungal Infections 
  Advance Healthcare Network
Sept. 24, 2014 T2 Biosystems Jumps on FDA Nod for Sepsis Tests
Sept. 24, 2014 T2 Biosystems Gains Clearance from FDA for Platform to Detect Sepsis
  Medical Device Daily
Sept. 24, 2014 US FDA Grants Marketing Authorization to T2 Biosystems' T2Candida & T2Dx for Detection of Sepsis-Causing Pathogens
Sept. 24, 2014 T2 Biosystems' Sepsis Tests Receive Clearance from FDA
  Bio SmartBrief
Sept. 23, 2014 Blood Test for Yeast Infections Approved
Sept. 23, 2014 T2 Biosystems Shares Spike on U.S. Approval for Faster Sepsis Test
  Boston Business Journal
Sept. 23, 2014 New Test for Candida Blood Stream Infection Offers Faster Results
Sept. 23, 2014 T2 Biosystems Wins FDA Approval for Sepsis Diagnostic System
Sept. 23, 2014 FDA Approves First Direct Blood Test for Detection of Yeast Pathogens
Sept. 23, 2014 FDA Clears Rapid Blood Test for Sepsis-Causing Pathogens
Sept. 23, 2014 FDA Clears New Rapid Test for Candida Infections of Bloodstream
Sept. 23, 2014 With FDA Nod, T2 Bio's Sepsis Test Heads to Commercial Proving Ground
Sept. 23, 2014 T2 Gains on Approval of Fungal Tests
  BioCentury Extra
Sept. 23, 2014 FDA Clears T2 Bio Test, System for Identification of Yeast Pathogens
  GenomeWeb Daily News
Sept. 22, 2014 FDA Allows Marketing of First Test for Yeast Pathogens
Sept. 22, 2014 T2 Biosystems Gains FDA Signoff for Time-Saving Candida Dx
Sept. 22, 2014 T2 Biosystems Receives FDA Authorization to Market T2Candida and T2Dx for Detection of Sepsis-Causing Pathogens
Sept. 1, 2014 FDA Green Lights Yeast Pathogen Detecting Blood Test
  FDA News
Aug. 8, 2014 T2 Prices Its IPO Shares at $11 Each
  The Boston Globe
Aug. 7, 2014 T2 Biosystems Prices 5.2 Shares in IPO at $11 Per Share
  Private Equity & Venture Capital Dow Jones
Aug. 6, 2014 T2 Biosystems Slated To Go Public this Week in Increasingly Uncertain Market
  Boston Business Journal
Jul. 2, 2014 T2 Biosystems, Bullish on New Candida Dx, Files IPO Plans
Jun. 4, 2014 T2 Biosystems Files for U.S. Approval of Fast-acting Sepsis Test
  Boston Business Journal
Jun. 3, 2014 T2 Biosystems Files for FDA Clearance for Dx System Candida Assay
Apr. 10, 2014

T2 Biosystems Presents New Data at the Thrombosis and Hemostasis Summit of North America Demonstrating Ability of T2MR Platform Technology to Measure Platelet Activity and Additional Hemostasis Parameters



Sept. 9, 2013 T2 Jumps into Pivotal Trial for Candida Assay
Jul. 22, 2013 T2 Biosystems Aims to Revolutionize Diagnostics
Apr. 24, 2013 Blood Test may Catch Deadly Fungal Infection Quickly
Jan. 8, 2013 JPM: T2 Readies Pivotal Trial for Candida Assay


Nov. 14, 2012 T2 Biosystems Gets Two More Patents for Assay
Oct. 2, 2012 T2 Biosystems – 2012 Fierce 15
Feb. 2, 2012 T2 Biosystems Wins Broad Patent for NMR-based Diagnostics
Jan. 20, 2012 T2 Biosystems Preps Clinical Trial for Candida Test in Anticipation of FDA Submission


Aug. 22, 2011 Nano-NMR for Diagnostics
  BioCentury on BioBusiness
Aug. 10, 2011 T2 Biosystems Closes $23M More for Fast, Cheap Diagnostic Tools
May 17, 2011 MIT Spinoff, T2 Biosystems, Hopes to Slash Deadly Hospital Infection Deaths
Apr. 15, 2011 New Test Spots Infections in Hours, Rather than Days
  MIT Technology Review